ArticleOpen forum infectious diseases2023

Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE).

Michael G Ison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.